These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38266938)

  • 21. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating sensors for monitoring blend content in a pharmaceutical continuous manufacturing plant.
    Panikar S; Li J; Rane V; Gillam S; Callegari G; Kurtyka B; Lee S; Muzzio F
    Int J Pharm; 2021 Sep; 606():120085. PubMed ID: 33737095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Approach to Screen the Capability of Raman and Infrared (Mid- and Near-) Spectroscopy for Quantification of Low-Active Pharmaceutical Ingredient Content Solid Dosage Forms: The Case of Alprazolam.
    Makraduli L; Makreski P; Goracinova K; Stefov S; Anevska M; Geskovski N
    Appl Spectrosc; 2020 Jun; 74(6):661-673. PubMed ID: 32031007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blend uniformity monitoring in a continuous manufacturing mixing process for a low-dosage formulation using a stream sampler and near infrared spectroscopy.
    Rangel-Gil RS; Nasrala-Álvarez JM; Romañach RJ; Méndez R
    Int J Pharm; 2024 Jul; ():124478. PubMed ID: 39019300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raman spectroscopy as a PAT for pharmaceutical blending: Advantages and disadvantages.
    Riolo D; Piazza A; Cottini C; Serafini M; Lutero E; Cuoghi E; Gasparini L; Botturi D; Marino IG; Aliatis I; Bersani D; Lottici PP
    J Pharm Biomed Anal; 2018 Feb; 149():329-334. PubMed ID: 29132112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of high-load dose formulations based on co-processed and non co-processed excipients.
    Sierra-Vega NO; Karry KM; Romañach RJ; Méndez R
    Int J Pharm; 2021 Sep; 606():120910. PubMed ID: 34298101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared spectroscopic applications in pharmaceutical particle technology.
    Razuc M; Grafia A; Gallo L; Ramírez-Rigo MV; Romañach RJ
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1565-1589. PubMed ID: 31282753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of NIR interfaces for the feeding and in-line monitoring of a continuous granulation process.
    Román-Ospino AD; Tamrakar A; Igne B; Towns Dimaso E; Airiau C; Clancy DJ; Pereira G; Muzzio FJ; Singh R; Ramachandran R
    Int J Pharm; 2020 Jan; 574():118848. PubMed ID: 31812798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of an in-line NIR spectroscopic method for continuous blend potency determination in the feed frame of a tablet press.
    De Leersnyder F; Peeters E; Djalabi H; Vanhoorne V; Van Snick B; Hong K; Hammond S; Liu AY; Ziemons E; Vervaet C; De Beer T
    J Pharm Biomed Anal; 2018 Mar; 151():274-283. PubMed ID: 29413975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
    Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous downstream processing of milled electrospun fibers to tablets monitored by near-infrared and Raman spectroscopy.
    Szabó E; Záhonyi P; Gyürkés M; Nagy B; Galata DL; Madarász L; Hirsch E; Farkas A; Andersen SK; Vígh T; Verreck G; Csontos I; Marosi G; Nagy ZK
    Eur J Pharm Sci; 2021 Sep; 164():105907. PubMed ID: 34118411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of near infrared spectroscopic calibration models for in-line determination of low drug concentration, bulk density, and relative specific void volume within a feed frame.
    Ortega-Zúñiga C; la Rosa CP; Román-Ospino AD; Serrano-Vargas A; Romañach RJ; Méndez R
    J Pharm Biomed Anal; 2019 Feb; 164():211-222. PubMed ID: 30391810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Particle Surface Area and Adhesion Force in the Sticking Behavior of Pharmaceutical Powders.
    Capece M
    J Pharm Sci; 2019 Dec; 108(12):3803-3813. PubMed ID: 31473214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Application of Control Concepts for Twin-Screw Wet Granulation in the ConsiGma
    Celikovic S; Poms J; Khinast J; Horn M; Rehrl J
    Int J Pharm; 2024 May; 657():124124. PubMed ID: 38636678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-line monitoring of Ibuprofen during and after tablet compression using near-infrared spectroscopy.
    Dalvi H; Langlet A; Colbert MJ; Cournoyer A; Guay JM; Abatzoglou N; Gosselin R
    Talanta; 2019 Apr; 195():87-96. PubMed ID: 30625630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.